Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_assertion type Assertion NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_head.
- NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_assertion description "[Selective orexin receptor antagonism takes advantage of these properties toward the development of novel insomnia therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_provenance.
- NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_assertion evidence source_evidence_literature NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_provenance.
- NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_assertion SIO_000772 22759794 NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_provenance.
- NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_assertion wasDerivedFrom befree-2016 NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_provenance.
- NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_assertion wasGeneratedBy ECO_0000203 NP994891.RA2z26quSUB0yI-P-cZQ2uFxvrtCG34y87D1V--1nCnio130_provenance.